Search Results 61-70 of 997 for 🌟텔문의2만지급 토토오톡티비.COM 꽁머니사이트🌟

  1. A Study to Identify Risk Factors for 30-Day Readmission - Mayo Clinic

    The primary purpose of this study is to collect data on patient-identified factors which contribute to readmissions to the Mayo Clinic Hospital Medicine ...

  2. A Study of the Effectiveness and Safety of Ofatumumab Compared to Teriflunomide for the Treatment of Patients with Relapsing Multiple Sclerosis - Mayo Clinic

    Participation eligibility · Diagnosis of multiple sclerosis (MS) · Relapsing MS (RRMS or SPMS) course · At least 1 relapse during the previous 1 year, 2 relapses ...

  3. A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection - Mayo Clinic

    ... 2, 3, 4, 5 or 6 Infection. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

  5. A Study to Assess Markers of Aging Process - Mayo Clinic

    ***Not enrolling for cohort 2 at this time. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  6. Point of Care Lateral Flow Assay for Coccidioidomycosis - Mayo Clinic

    ... 2 weeks of the lateral flow assay. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  7. Podocyturia in Diabetes Mellitus Type 2 and Proteinuric Glomerulonephritides - Mayo Clinic

    The goal of this study is to evaluate the presence of podocytes (special cells in the kidney that prevent protein loss) in the urine in patients with diabetes ...

  8. Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

    The objective of this study is to assess the safety and tolerability, including the maximum tolerated dose, of ASP2215 in subjects with relapsed or treatment- ...

  9. A Study to Compare the Effectiveness of Invasive versus Conservative Medical Approaches in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease - Mayo Clinic

    About this study. The purpose of the ISCHEMIA-CKD trial is to determine the best management strategy for patients with stable ischemic heart disease (SIHD), ...

  10. ALN-TTR02-012 - Clinical Trials

    To evaluate the effectiveness of Patisiran on ambulatory status in patients with hATTR amyloidosis with polyneuropathy who have a V122I or T60A mutation.